Cargando…

Ophthalmic Manifestations of Hematopoietic Malignancy

Purpose. To report the ocular findings in patients with hematopoietic malignancy with optic nerve involvement and abducens nerve palsy. Methods. The medical records of all cases of hematopoietic cancer with ophthalmic involvements seen in the Department of Ophthalmology of the National Center for Gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida-Hata, Natsuyo, Katai, Naomichi, Oshitari, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914723/
https://www.ncbi.nlm.nih.gov/pubmed/27375913
http://dx.doi.org/10.1155/2016/6074968
_version_ 1782438586060111872
author Yoshida-Hata, Natsuyo
Katai, Naomichi
Oshitari, Toshiyuki
author_facet Yoshida-Hata, Natsuyo
Katai, Naomichi
Oshitari, Toshiyuki
author_sort Yoshida-Hata, Natsuyo
collection PubMed
description Purpose. To report the ocular findings in patients with hematopoietic malignancy with optic nerve involvement and abducens nerve palsy. Methods. The medical records of all cases of hematopoietic cancer with ophthalmic involvements seen in the Department of Ophthalmology of the National Center for Global Health and Medicine between 2009 and 2014 were reviewed. Results. Eight patients with hematopoietic cancer with optic nerve invasion or abducens nerve palsy were studied. The primary diseases were 3 cases of multiple myeloma, 1 case of acute lymphocytic leukemia, 1 case of follicular lymphoma, and 3 cases of AIDS-related lymphoma. Six cases had optic nerve invasion, 2 cases had abducens nerve palsy, and 1 case had optic nerve invasion of both eyes. The median visual acuity of eyes with optic nerve invasion was 0.885 logarithm of the minimum angle of resolution (logMAR) units. The final visual acuity of eyes with optic nerve invasion was 1.25 logMAR units, and that of those with sixth-nerve palsy was −0.1 logMAR units. Six cases died during the five-year follow-up period. An ophthalmic involvement in patients with hematopoietic cancer, especially AIDS-related lymphoma, was associated with poor prognosis. Conclusion. Because ophthalmic involvement in patients with hematopoietic malignancy has a poor prognosis, an early diagnosis of the cancers by the ophthalmologic findings by ophthalmologists could improve the prognosis.
format Online
Article
Text
id pubmed-4914723
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-49147232016-07-03 Ophthalmic Manifestations of Hematopoietic Malignancy Yoshida-Hata, Natsuyo Katai, Naomichi Oshitari, Toshiyuki Case Rep Ophthalmol Med Case Report Purpose. To report the ocular findings in patients with hematopoietic malignancy with optic nerve involvement and abducens nerve palsy. Methods. The medical records of all cases of hematopoietic cancer with ophthalmic involvements seen in the Department of Ophthalmology of the National Center for Global Health and Medicine between 2009 and 2014 were reviewed. Results. Eight patients with hematopoietic cancer with optic nerve invasion or abducens nerve palsy were studied. The primary diseases were 3 cases of multiple myeloma, 1 case of acute lymphocytic leukemia, 1 case of follicular lymphoma, and 3 cases of AIDS-related lymphoma. Six cases had optic nerve invasion, 2 cases had abducens nerve palsy, and 1 case had optic nerve invasion of both eyes. The median visual acuity of eyes with optic nerve invasion was 0.885 logarithm of the minimum angle of resolution (logMAR) units. The final visual acuity of eyes with optic nerve invasion was 1.25 logMAR units, and that of those with sixth-nerve palsy was −0.1 logMAR units. Six cases died during the five-year follow-up period. An ophthalmic involvement in patients with hematopoietic cancer, especially AIDS-related lymphoma, was associated with poor prognosis. Conclusion. Because ophthalmic involvement in patients with hematopoietic malignancy has a poor prognosis, an early diagnosis of the cancers by the ophthalmologic findings by ophthalmologists could improve the prognosis. Hindawi Publishing Corporation 2016 2016-06-07 /pmc/articles/PMC4914723/ /pubmed/27375913 http://dx.doi.org/10.1155/2016/6074968 Text en Copyright © 2016 Natsuyo Yoshida-Hata et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Yoshida-Hata, Natsuyo
Katai, Naomichi
Oshitari, Toshiyuki
Ophthalmic Manifestations of Hematopoietic Malignancy
title Ophthalmic Manifestations of Hematopoietic Malignancy
title_full Ophthalmic Manifestations of Hematopoietic Malignancy
title_fullStr Ophthalmic Manifestations of Hematopoietic Malignancy
title_full_unstemmed Ophthalmic Manifestations of Hematopoietic Malignancy
title_short Ophthalmic Manifestations of Hematopoietic Malignancy
title_sort ophthalmic manifestations of hematopoietic malignancy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914723/
https://www.ncbi.nlm.nih.gov/pubmed/27375913
http://dx.doi.org/10.1155/2016/6074968
work_keys_str_mv AT yoshidahatanatsuyo ophthalmicmanifestationsofhematopoieticmalignancy
AT katainaomichi ophthalmicmanifestationsofhematopoieticmalignancy
AT oshitaritoshiyuki ophthalmicmanifestationsofhematopoieticmalignancy